Rockefeller Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Buy
31,007
+30,349
+4,612% +$379K ﹤0.01% 2193
2025
Q4
$8.51K Buy
658
+82
+14% +$1.05K ﹤0.01% 3875
2025
Q3
$7.44K Buy
+576
New +$7.7K ﹤0.01% 3759
2023
Q1
Sell
-1,280
Closed -$93K 3248
2022
Q4
$93K Sell
1,280
-7,846
-86% -$590K ﹤0.01% 2068
2022
Q3
$693K Hold
9,126
﹤0.01% 1148
2022
Q2
$634K Sell
9,126
-2,590
-22% -$195K ﹤0.01% 1169
2022
Q1
$970K Buy
11,716
+70
+0.6% +$5.16K ﹤0.01% 1069
2021
Q4
$874K Buy
11,646
+1,771
+18% +$178K ﹤0.01% 1099
2021
Q3
$1.15M Buy
9,875
+8,624
+689% +$1.3M 0.01% 950
2021
Q2
$276K Buy
1,251
+285
+30% +$55.4K ﹤0.01% 1394
2021
Q1
$127K Sell
966
-12
-1% -$1.9K ﹤0.01% 1504
2020
Q4
$169K Buy
978
+690
+240% +$94.4K ﹤0.01% 1251
2020
Q3
$32K Hold
288
﹤0.01% 1639
2020
Q2
$17K Hold
288
﹤0.01% 1728
2020
Q1
$19K Buy
+288
New +$22.8K ﹤0.01% 1536

Other funds holding NVCR